ACADIAN ASSET MANAGEMENT LLC - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$1,376
-65.9%
147,073
-10.6%
0.01%
-64.7%
Q2 2023$4,033
-1.6%
164,483
-6.6%
0.02%
-5.6%
Q1 2023$4,099
+48.5%
176,196
+61.5%
0.02%
+28.6%
Q4 2022$2,760
-99.9%
109,093
-45.3%
0.01%
-33.3%
Q3 2022$3,843,000
+5.3%
199,417
+39.2%
0.02%
+10.5%
Q2 2022$3,648,000
+1751.8%
143,249
+1756.0%
0.02%
+1800.0%
Q1 2022$197,000
-1.5%
7,718
+65.8%
0.00%0.0%
Q3 2021$200,0004,6550.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$36,281,23432.04%
SB INVESTMENT ADVISERS (UK) LTD 18,319,938$426,304,9573.50%
Zebra Capital Management LLC 27,110$6313.15%
Avidity Partners Management LP 1,640,200$38,167,4541.27%
Sofinnova Investments, Inc. 657,559$15,301,3980.98%
DCF Advisers, LLC 62,000$1,442,7400.88%
SECTOR GAMMA AS 145,545$3,386,8320.82%
Temasek Holdings (Private) Ltd 5,814,972$135,314,3980.80%
BRAIDWELL LP 604,036$14,055,9180.46%
SummerHaven Investment Management, LLC 26,045$606,0670.35%
View complete list of VIR BIOTECHNOLOGY INC shareholders